Synthesis and evaluation of delta lactams as nonpeptide HIV-protease inhibitors

Bioorganic and Medicinal Chemistry Letters

Volumn 7, Issue 5, 1997, Pages 501-504

  De Lucca, George V ^a  

^a DUPONT COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LACTAM; PROTEINASE INHIBITOR;

ARTICLE; DRUG DESIGN; DRUG SYNTHESIS; ENZYME INHIBITION; HUMAN IMMUNODEFICIENCY VIRUS; IN VITRO STUDY; STRUCTURE ACTIVITY RELATION;

EID: 0031552144     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(97)00007-3     Document Type: Article

References (20)

1. 1. For a recent reviews see: (a) De Clercq, E. J. Med. Chem. 1995, 38, 2491.
2. (b) Chong, K. T. Exp. Opin. Invest. Drugs 1996, 5, 115.
3. 2. (a) Wei, X.; Ghosh, S. K.; Taylor, M. E.; Johnson, V. A.; Emini, E. A.; Deutsch, P.; Lifson, J. D.; Bonhoeffer, S.; Nowak, M. A.; Hahn, B. H.; Saag, M. S.; Shaw, G. M. Nature 1995, 373, 117.
4. (b) Ho, D. D.; Neumann, A. U.; Perelson, A. S.; Chen, W.; Leonard, J. M.; Markowitz, M. Nature 1995, 373, 123.
5. (c) Kitchen, V. S.; Skinner, C.; Ariyoshi, K.; Lane, E. A.; Duncan, I. B.; Burckhardt, J.; Burger, H. U.; Bragman, K.; Pinching, A. J.; Weber, J. N. The Lancet. 1995, 345, 952.
6. 3. (a) Jacobsen, H.; Yasargil, K.; Winslow, D. L.; Craig, J. C.; Krohn, A.; Duncan, I. B.; Mous, J. Virology. 1995, 206, 527.
7. (b) Markowitz, M. M.; Mo, H.; Kempf, D. J.; Norbeck, D. W.; Bhat, T. N.; Erickson, J. W.; Ho, D. J. Virol. 1995, 69, 701.
8. (c) Condra, J. H.; Schlelf, W. A.; Blahy, O. M.; Gabryelski, L. J.; Graham, D. J.; Quintero, J. C.; Rhodes, A.; Robbins, H. L.; Roth, E.; Shivaprakash, M.; Titus, D., Yang, T.; Teppler, H.; Squires, K. E.; Deutsch, P. J.; Emini, E. A. Nature. 1995, 374, 569.
9. (d) Ridky, T.; Leis, J. J. Biol. Chem. 1995, 270, 29621.
10. 4. Lam, P. Y. S.; Jadhav, P. K.; Eyermann, C. J.; Hodge, C. N.; Ru, Y.; Bacheler, L. T.; Meek, J. L.; Otto, M. J.; Rayner, M. M.; Wong, N. Y.; Chang, C-H.; Weber, P. C.; Jackson, D. A.; Sharpe, T. R.; Erickson-Viitanen, S. Science 1994, 263, 380.
11. 5. (a) Lam, P. Y. S.; Ru, Y.; Jadhav, P. K.; Aldrich, P. E.; De Lucca, G. V.; Eyermann, C. J.; Chang, C-H.; Emmett, G.; Holler, E. R.; Daneker, W. F.; Li, L.; Confalone, P. N.; McHugh, R. J.; Han, Q.; Markwalder, J. A.; Seitz, S. P.; Bacheler, L. T.; Rayner, M. M.; Klabe, R. M.; Shum, L.; Winslow, D. L.; Kornhauser, D. M.; Jackson, D. A.; Erickson-Viitanen, S.; Sharpe, T. R.; Hodge, C. N. J. Med. Chem. 1996, 39, 3514.
12. (b) Wong, Y. N.; Burcham, D. L.; Saxten, P. L.; Erickson-Viitanen, S.; Grubb, M. F.; Quon, C. Y.; Huang, S-M. Biopharm. Drug. Dispos. 1994, 15, 535.
13. 6. Hodge, C. N.; Aldrich, P. E.; Bacheler, L. T.; Chang, C-H.; Eyermann, C. J.; Garber, S.; Grubb, M.; Jackson, D. A.; Jadhav, P. K.; Korant, B.; Lam, P. Y. S.; Maurin, M. B.; Meek, J. L.; Otto, M. J.; Rayner, M. M.; Reid, C.; Sharpe, T. R.; Shum, L.; Winslow, D. L.; Erickson-Viitanen, S. Chemistry and Biology 1996, 3, 301.
14. 7. (a) De Lucca, G. V.; Lam, P. Y. S.; Chang, C-H.; Meek, J.; Rayner, M.; Erickson-Viitanen, S. Presented at the 209th National Meeting of the American Chemical Society, Anaheim, CA, April 1995, Div. of Med. Chem., No. 004.
15. (b) De Lucca, G. V.; Calabrese, J.; Liang, J.; Lam, P. Y. S.; Chang, C-H.; Meek, J.; Rayner, M.; Erickson-Viitanen, S. Presented at the 1995 International Chemical Congress of Pacific Basin Societies, December 17-22, 1995, Org. Chem. No. 631.
16. (c) De Lucca, G. V.; Calabrese, J.; Meek, J.; Rayner, M. Presented at the 209th ACS National Meeting, Anaheim, CA, April 1995, Division of Org. Chem., No. 514.
17. 8. Dreyer, G. B.; Lambert, D. M.; Meek, T. D.; Carr, T. J.; Tomaszek, T. A.; Fernandez, A. V.; Bartus, H.; Cacciavillani, E.; Hassel, A. M.; Minnich, M.; Petteway, Jr. S. R.; Metcalf, B. W. Biochemistry 1992, 31, 6646.
18. 9. Evans, B. E.; Rittle, K. E.; Homnick, C. F.; Springer, J. P.; Hirshfield, J.; Veber, D. F. J. Org. Chem. 1985, 50, 4615.
19. 10. Ki's were measured by Mr. R. Klabe as described previously in: Erickson-Viitanen, S.; Klabe, R. M.; Cadwood, P. G.; O'Neal, P. L.; Meek, J. L. Antimicrob. Agents Chemother. 1994, 38, 1628.
20. 11. In a later study a similar loss in potency was seen with 7-membered ring cyclic urea analogs lacking a P1' substituent. For example see: Nugiel, D. A.; Reese, K. Drug Design Disc. 1995, 13 , 82.